Postmarket Study of Tarvos Microguidewire in Neurovascular Interventional Surgery

Keuro MedTech121 enrolled

Overview

This investigation is to evaluate the clinical effectiveness and safety of the Tarvos Microguidewire in the neurovascular interventional surgery. It is a retrospective multicenter medical device clinical study with real-world data.

Study Type

OBSERVATIONAL

Enrollment

121

Conditions

Intracranial Aneurysm AVM - Cerebral Arteriovenous Malformation AV Fistula Acute Ischemic Stroke Extracranial Atherosclerosis

Interventions

Tarvos MicroguidewireDEVICE

This product is indicated for use in neurovascular interventions to assist in the delivery of diagnostic or therapeutic devices to the target lesion site.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Undertaken a neurovascular surgery procedure including Tarvos microguidewire * Available images of Tarvos Microguidewire in the neurovascular surgery. Exclusion Criteria: * Disorders of vascular fragility (e.g. Ehlers-Danlos syndrome) * Prior vascular dissection or injury to the target vessels * Not meeting the data requirements needed for this study.

Locations (1)

Xingtai central hospital

Xingtai, China

Outcomes

Primary Outcomes

Device success rate

Number of patients with device success / Number of recruited patients\* 100%

Time frame: during surgery

Secondary Outcomes

Ability to assist in the delivery of other interventional devices to the targeted vessel position.

Time frame: during surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.